Axinn partner Jeny Maier was quoted in the Mergermarket article, "Amgen/Horizon Therapeutics’ FTC Suit Carries Implications Beyond Pharmaceutical Mergers - Advisors." The article was also published in Dealreporter and PaRR.

Click here to access the article.